SSR-103,800
SSR-103,800
SSR-103,800 is a chemical compound that has been studied for its potential effects on the central nervous system. It is primarily known for its role as a selective antagonist of the neurokinin 3 receptor (NK3 receptor), which is a type of neurokinin receptor involved in various physiological processes.
Chemical Structure and Properties[edit | edit source]
SSR-103,800 is a small molecule with a specific chemical structure that allows it to selectively bind to the NK3 receptor. The precise molecular formula and structural details are crucial for its function as a receptor antagonist.
Mechanism of Action[edit | edit source]
As an NK3 receptor antagonist, SSR-103,800 works by blocking the action of neurokinin B, a neuropeptide that normally binds to and activates the NK3 receptor. This blockade can modulate neurotransmission and has been investigated for its potential therapeutic effects in various conditions.
Potential Therapeutic Applications[edit | edit source]
Research into SSR-103,800 has explored its use in treating conditions such as:
- Schizophrenia: By modulating neurotransmitter systems, SSR-103,800 may help alleviate some symptoms of schizophrenia.
- Mood disorders: Its effects on the central nervous system suggest potential benefits in treating mood disorders.
- Hot flashes: SSR-103,800 has been studied for its ability to reduce hot flashes in menopausal women by affecting the hypothalamic regulation of body temperature.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of SSR-103,800 includes its absorption, distribution, metabolism, and excretion. Understanding these parameters is essential for determining the appropriate dosing and potential side effects.
Research and Development[edit | edit source]
SSR-103,800 is still under investigation, and its development involves preclinical and clinical trials to assess its safety and efficacy. The outcomes of these studies will determine its potential as a therapeutic agent.
Safety and Side Effects[edit | edit source]
As with any pharmacological agent, the safety profile of SSR-103,800 is critical. Studies aim to identify any adverse effects and establish the therapeutic window for safe use.
Also see[edit | edit source]
 | This article about a biochemical receptor is a stub. You can help WikiMD by expanding it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
